These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3024199)

  • 1. Increased central alpha 2-adrenoceptor sensitivity in panic disorder.
    Nutt DJ
    Psychopharmacology (Berl); 1986; 90(2):268-9. PubMed ID: 3024199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered central alpha 2-adrenoceptor sensitivity in panic disorder.
    Nutt DJ
    Arch Gen Psychiatry; 1989 Feb; 46(2):165-9. PubMed ID: 2536539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks.
    Charney DS; Woods SW; Goodman WK; Heninger GR
    Am J Psychiatry; 1987 Aug; 144(8):1030-6. PubMed ID: 3037926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical response to clonidine and imipramine, and platelet alpha 2-adrenoreceptors in a case of agoraphobia with panic attacks.
    Zelnik TC; Garcia-Sevilla JA; Cameron OG; Smith CB
    Biol Psychiatry; 1982 Jun; 17(6):761-6. PubMed ID: 6285996
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of isoproterenol in panic disorder patients after antidepressant treatment.
    Pohl R; Yeragani VK; Balon R
    Biol Psychiatry; 1990 Aug; 28(3):203-14. PubMed ID: 2165824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal regulation of noradrenergic function in panic disorders. Effects of clonidine in healthy subjects and patients with agoraphobia and panic disorder.
    Charney DS; Heninger GR
    Arch Gen Psychiatry; 1986 Nov; 43(11):1042-54. PubMed ID: 3021083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrine, cardiovascular, and behavioral responses to clonidine in patients with panic disorder.
    Abelson JL; Glitz D; Cameron OG; Lee MA; Bronzo M; Curtis GC
    Biol Psychiatry; 1992 Jul; 32(1):18-25. PubMed ID: 1391293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral and physiologic effects of short-term and long-term administration of clonidine in panic disorder.
    Uhde TW; Stein MB; Vittone BJ; Siever LJ; Boulenger JP; Klein E; Mellman TA
    Arch Gen Psychiatry; 1989 Feb; 46(2):170-7. PubMed ID: 2643934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart rate and blood pressure during placebo-associated panic attacks.
    Balon R; Ortiz A; Pohl R; Yeragani VK
    Psychosom Med; 1988; 50(4):434-8. PubMed ID: 3045849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reserpine induces vascular alpha 2-adrenergic supersensitivity and platelet alpha 2-adrenoceptor up-regulation in dog.
    Estan L; Senard JM; Tran MA; Montastruc JL; Berlan M
    Br J Pharmacol; 1990 Oct; 101(2):329-36. PubMed ID: 2175232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central alpha 2-adrenoceptor-mediated pressor response to clonidine in conscious, spontaneously hypertensive rats.
    Kawasaki H; Nakamura S; Takasaki K
    Jpn J Pharmacol; 1992 Jul; 59(3):321-31. PubMed ID: 1331587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential blood pressure responses to intracisternal clonidine, alpha-methyldopa, and 6-hydroxydopamine in conscious normotensive and spontaneously hypertensive rats.
    Head GA; de Jong W
    J Cardiovasc Pharmacol; 1986; 8(4):735-42. PubMed ID: 2427812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible role of an endogenous opiate in the cardiovascular effects of central alpha adrenoceptor stimulation in spontaneously hypertensive rats.
    Farsang C; Ramirez-Gonzalez MD; Mucci L; Kunos G
    J Pharmacol Exp Ther; 1980 Jul; 214(1):203-8. PubMed ID: 6248627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular responses to central clonidine, alpha-methyldopa, and 6-hydroxydopamine in conscious normotensive and spontaneously hypertensive rats following naloxone.
    Head GA; de Jong W
    J Cardiovasc Pharmacol; 1985; 7(2):321-6. PubMed ID: 2581087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential inhibitory noradrenergic responses to clonidine in 25 depressed patients and 25 normal control subjects.
    Siever LJ; Uhde TW; Jimerson DC; Lake CR; Silberman ER; Post RM; Murphy DL
    Am J Psychiatry; 1984 Jun; 141(6):733-41. PubMed ID: 6329004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Spinal alpha-adrenoceptor and dynorphin involvement in the depressor effect of clonidine].
    Xie CW; Han JS
    Zhongguo Yao Li Xue Bao; 1984 Dec; 5(4):235-8. PubMed ID: 6152646
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative effects of urapidil, prazosin, and clonidine on ligand binding to central nervous system receptors, arterial pressure, and heart rate in experimental animals.
    Kellar KJ; Quest JA; Spera AC; Buller A; Conforti A; Dias Souza J; Gillis RA
    Am J Med; 1984 Oct; 77(4A):87-95. PubMed ID: 6091452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenergic function in patients with panic anxiety.
    Nesse RM; Cameron OG; Curtis GC; McCann DS; Huber-Smith MJ
    Arch Gen Psychiatry; 1984 Aug; 41(8):771-6. PubMed ID: 6331337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of thyrotropin-releasing hormone on blood pressure and heart rate in phobic and panic patients: a pilot study.
    Tancer ME; Stein MB; Uhde TW
    Biol Psychiatry; 1990 Apr; 27(7):781-3. PubMed ID: 2109640
    [No Abstract]   [Full Text] [Related]  

  • 20. Blunted growth hormone response to clonidine in patients with generalized anxiety disorder.
    Abelson JL; Glitz D; Cameron OG; Lee MA; Bronzo M; Curtis GC
    Arch Gen Psychiatry; 1991 Feb; 48(2):157-62. PubMed ID: 1989571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.